Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

by Global Biodefense Staff September 2, 2020, 2:12 pm
CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

by Global Biodefense Staff May 19, 2020, 4:00 pm
AFRL Adapts Pararescue Tactics for COVID-19 Monitoring

by Global Biodefense Staff May 15, 2020, 8:53 am
AFRL Aircraft Decontamination Team Ramps Up Battle Against COVID-19

by Global Biodefense Staff April 29, 2020, 2:00 pm
Isolation Chamber Invented by Army Doctors Protects Staff from Pathogens

by Global Biodefense Staff April 21, 2020, 10:00 am
USAMRIID Gears Up to Fight COVID-19

by Global Biodefense Staff April 1, 2020, 2:19 pm
Meet the Army Lieutenant Racing to Develop a Coronavirus Vaccine

by Global Biodefense Staff March 25, 2020, 8:53 am
USAMRIID: America’s Key Lab for Fighting Infectious Diseases Has Become a Pentagon Backwater

by Global Biodefense Staff March 21, 2020, 5:36 pm
Why is the Defense Department Withholding Funding for USAMRIID and CCDC Chemical Biological Center?

by Global Biodefense Staff February 5, 2020, 7:19 pm
DoD: Take Common Sense Measures Against Novel Coronavirus

by Global Biodefense Staff January 28, 2020, 1:11 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Suspending Threats in Mid-Air: Army Laser Beam Capable of Detecting Chem-Bio Warfare Agents

by Global Biodefense Staff January 14, 2020, 11:17 pm
Threat Detection in Your Pocket

by Global Biodefense Staff November 25, 2019, 11:25 am
Innovators Gather to Defend Against Chemical and Biological Weapons

by Global Biodefense Staff November 18, 2019, 9:53 am
Mount Sinai Receives U.S. Military Contract to Identify Exposure to Weaponized Infectious Agents

by Global Biodefense Staff October 10, 2019, 10:02 am

Congratulations. You've reached the end of the internet.

Defense + Military

Naval Research Lab Evaluates Ultraviolet Sources Against SARS-CoV-2

W. Virginia CBRN Response Enterprise Assists with COVID-19 Testing Innovation Roll Out

USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

CCDC Chemical Biological Center Strives to Become DoD’s Biomanufacturing Leader

AFRL Adapts Pararescue Tactics for COVID-19 Monitoring

AFRL Aircraft Decontamination Team Ramps Up Battle Against COVID-19

Isolation Chamber Invented by Army Doctors Protects Staff from Pathogens

USAMRIID Gears Up to Fight COVID-19

Meet the Army Lieutenant Racing to Develop a Coronavirus Vaccine

USAMRIID: America’s Key Lab for Fighting Infectious Diseases Has Become a Pentagon Backwater

Why is the Defense Department Withholding Funding for USAMRIID and CCDC Chemical Biological Center?

DoD: Take Common Sense Measures Against Novel Coronavirus

Suspending Threats in Mid-Air: Army Laser Beam Capable of Detecting Chem-Bio Warfare Agents

Threat Detection in Your Pocket

Innovators Gather to Defend Against Chemical and Biological Weapons

Mount Sinai Receives U.S. Military Contract to Identify Exposure to Weaponized Infectious Agents

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles

Defense + Military CBRN News